Zhao Xinbin, Ding Yuecheng, Du Jing, Fan Yubo
Key Laboratory for Biomechanics and Mechanobiology of Chinese Education Ministry, School of Biological Science and Medical Engineering, Beihang University, Beijing, 100191, China.
School of Public Health, Peking University, Beijing, 100871, China.
Med Nov Technol Devices. 2020 Dec;8:100043. doi: 10.1016/j.medntd.2020.100043. Epub 2020 Aug 29.
Since human coronavirus (HCoVs) was first described in the 1960s, seven strains of respiratory human coronaviruses have emerged and caused human infections. After the emergence of severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), a pneumonia outbreak of coronavirus disease 2019 (COVID-19) caused by a novel coronavirus (SARS-CoV-2) has represented a pandemic threat to global public health in the 21st century. Without effectively prophylactic and therapeutic strategies including vaccines and antiviral drugs, these three coronaviruses have caused severe respiratory syndrome and high case-fatality rates around the world. In this review, we detail the emergence event, origin and reservoirs of all HCoVs, compare the differences with regard to structure and receptor usage, and summarize therapeutic strategies for COVID-19 that cause severe pneumonia and global pandemic.
自20世纪60年代首次发现人类冠状病毒(HCoV)以来,已出现七种呼吸道人类冠状病毒毒株并引发人类感染。在严重急性呼吸综合征冠状病毒(SARS-CoV)和中东呼吸综合征冠状病毒(MERS-CoV)出现后,由新型冠状病毒(SARS-CoV-2)引起的2019冠状病毒病(COVID-19)肺炎疫情已对21世纪全球公共卫生构成大流行威胁。由于缺乏包括疫苗和抗病毒药物在内的有效预防和治疗策略,这三种冠状病毒已在全球范围内导致严重的呼吸综合征和高病死率。在本综述中,我们详细介绍了所有人类冠状病毒的出现事件、起源和宿主,比较了它们在结构和受体使用方面的差异,并总结了针对导致严重肺炎和全球大流行的2019冠状病毒病的治疗策略。